APO RESEARCH · REPORT
Veterinary Zinc Bacitracin
Zinc Bacitracin is a mixture of high-molecular-weight polypeptides (bacitracin A, B, C, and several minor components). Zinc Bacitracin occurs as a yellowish gray-brown to brown powder. It has characteristic odor. It is freely soluble in dilute hydrochloric acid, water, pyridine, and menthol. Bacitracin has antibacterial effect on Gram-negative bacteria, actinomycetes, and leptospirae, and strong antibacterial effect on Gram-positive bacteria. It has growth-promoting effect on chickens (including broilers), pigs, and cattle.
Product & engineering
Understand the product.
Zinc Bacitracin is a mixture of high-molecular-weight polypeptides (bacitracin A, B, C, and several minor components). Zinc Bacitracin occurs as a yellowish gray-brown to brown powder. It has characteristic odor. It is freely soluble in dilute hydrochloric acid, water, pyridine, and menthol. Bacitracin has antibacterial effect on Gram-negative bacteria, actinomycetes, and leptospirae, and strong antibacterial effect on Gram-positive bacteria. It has growth-promoting effect on chickens (including broilers), pigs, and cattle.
Selected research
Industry Research
Veterinary Zinc Bacitracin Industry Research Report 2026
Market perspective
Zinc Bacitracin is a mixture of high-molecular-weight polypeptides (bacitracin A, B, C, and several minor components). Zinc Bacitracin occurs as a yellowish gray-brown to brown powder. It has characteristic odor. It is freely soluble in dilute hydrochloric acid, water, pyridine, and menthol. Bacitracin has antibacterial effect on Gram-negative bacteria, actinomycetes, and leptospirae, and strong antibacterial effect on Gram-positive bacteria. It has growth-promoting effect on chickens (including broilers), pigs, and cattle.
In 2018, Lifecome Biochemistry is considered to be the global market leader with a 26% share of production.
Top 5 manufacturers occupied about 74% market in 2018.
Read the full market overview
China was the largest production region in the past few years, with a proportion of 65%.
Asia Pacific was the largest consumption region, which occupied 1/3 market during the past few years.
Report Scope
This report quantifies the global Veterinary Zinc Bacitracin market in revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Veterinary Zinc Bacitracin.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Zinc Bacitracin Market by Company
Zoetis
Ceva Corporate
Huvepharma
Lifecome Biochemistry
Qilu Pharmaceutical
Orion Animal Nutrition
Vega Pharma
Tianjin Xinxing Veterinary Pharmaceutical
Veterinary Zinc Bacitracin Segment by Type
10% Zinc Bacitracin
15% Zinc Bacitracin
Veterinary Zinc Bacitracin Segment by Application
Pigs
Cattle
Chicken
Others
Veterinary Zinc Bacitracin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Zinc Bacitracin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Zinc Bacitracin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Zinc Bacitracin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Zinc Bacitracin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Zinc Bacitracin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Zinc Bacitracin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10% Zinc Bacitracin
- 15% Zinc Bacitracin
Applications
- Pigs
- Cattle
- Chicken
- Others
Companies covered
- Zoetis
- Ceva Corporate
- Huvepharma
- Lifecome Biochemistry
- Qilu Pharmaceutical
- Orion Animal Nutrition
- Vega Pharma
- Tianjin Xinxing Veterinary Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Veterinary Zinc Bacitracin by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 10% Zinc Bacitracin
- 2.2.3 15% Zinc Bacitracin
- 2.3 Veterinary Zinc Bacitracin by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pigs
- 2.3.3 Cattle
- 2.3.4 Chicken
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Veterinary Zinc Bacitracin Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Veterinary Zinc Bacitracin Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Veterinary Zinc Bacitracin Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Veterinary Zinc Bacitracin Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veterinary Zinc Bacitracin Production by Manufacturers (2021-2026)
- 3.2 Global Veterinary Zinc Bacitracin Production Value by Manufacturers (2021-2026)
- 3.3 Global Veterinary Zinc Bacitracin Average Price by Manufacturers (2021-2026)
- 3.4 Global Veterinary Zinc Bacitracin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Veterinary Zinc Bacitracin Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Veterinary Zinc Bacitracin Manufacturers, Product Type & Application
- 3.7 Global Veterinary Zinc Bacitracin Manufacturers Established Date
- 3.8 Global Veterinary Zinc Bacitracin Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Veterinary Zinc Bacitracin Company Information
- 4.1.2 Zoetis Veterinary Zinc Bacitracin Business Overview
- 4.1.3 Zoetis Veterinary Zinc Bacitracin Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Zoetis Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Ceva Corporate
- 4.2.1 Ceva Corporate Veterinary Zinc Bacitracin Company Information
- 4.2.2 Ceva Corporate Veterinary Zinc Bacitracin Business Overview
- 4.2.3 Ceva Corporate Veterinary Zinc Bacitracin Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Ceva Corporate Product Portfolio
- 4.2.5 Ceva Corporate Recent Developments
- 4.3 Huvepharma
- 4.3.1 Huvepharma Veterinary Zinc Bacitracin Company Information
- 4.3.2 Huvepharma Veterinary Zinc Bacitracin Business Overview
- 4.3.3 Huvepharma Veterinary Zinc Bacitracin Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Huvepharma Product Portfolio
- 4.3.5 Huvepharma Recent Developments
- 4.4 Lifecome Biochemistry
- 4.4.1 Lifecome Biochemistry Veterinary Zinc Bacitracin Company Information
- 4.4.2 Lifecome Biochemistry Veterinary Zinc Bacitracin Business Overview
- 4.4.3 Lifecome Biochemistry Veterinary Zinc Bacitracin Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Lifecome Biochemistry Product Portfolio
- 4.4.5 Lifecome Biochemistry Recent Developments
- 4.5 Qilu Pharmaceutical
- 4.5.1 Qilu Pharmaceutical Veterinary Zinc Bacitracin Company Information
- 4.5.2 Qilu Pharmaceutical Veterinary Zinc Bacitracin Business Overview
- 4.5.3 Qilu Pharmaceutical Veterinary Zinc Bacitracin Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Qilu Pharmaceutical Product Portfolio
- 4.5.5 Qilu Pharmaceutical Recent Developments
- 4.6 Orion Animal Nutrition
- 4.6.1 Orion Animal Nutrition Veterinary Zinc Bacitracin Company Information
- 4.6.2 Orion Animal Nutrition Veterinary Zinc Bacitracin Business Overview
- 4.6.3 Orion Animal Nutrition Veterinary Zinc Bacitracin Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Orion Animal Nutrition Product Portfolio
- 4.6.5 Orion Animal Nutrition Recent Developments
- 4.7 Vega Pharma
- 4.7.1 Vega Pharma Veterinary Zinc Bacitracin Company Information
- 4.7.2 Vega Pharma Veterinary Zinc Bacitracin Business Overview
- 4.7.3 Vega Pharma Veterinary Zinc Bacitracin Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Vega Pharma Product Portfolio
- 4.7.5 Vega Pharma Recent Developments
- 4.8 Tianjin Xinxing Veterinary Pharmaceutical
- 4.8.1 Tianjin Xinxing Veterinary Pharmaceutical Veterinary Zinc Bacitracin Company Information
- 4.8.2 Tianjin Xinxing Veterinary Pharmaceutical Veterinary Zinc Bacitracin Business Overview
- 4.8.3 Tianjin Xinxing Veterinary Pharmaceutical Veterinary Zinc Bacitracin Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Tianjin Xinxing Veterinary Pharmaceutical Product Portfolio
- 4.8.5 Tianjin Xinxing Veterinary Pharmaceutical Recent Developments
5 Global Veterinary Zinc Bacitracin Production by Region
- 5.1 Global Veterinary Zinc Bacitracin Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veterinary Zinc Bacitracin Production by Region: 2021-2032
- 5.2.1 Global Veterinary Zinc Bacitracin Production by Region: 2021-2026
- 5.2.2 Global Veterinary Zinc Bacitracin Production Forecast by Region (2027-2032)
- 5.3 Global Veterinary Zinc Bacitracin Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Veterinary Zinc Bacitracin Production Value by Region: 2021-2032
- 5.4.1 Global Veterinary Zinc Bacitracin Production Value by Region: 2021-2026
- 5.4.2 Global Veterinary Zinc Bacitracin Production Value Forecast by Region (2027-2032)
- 5.5 Global Veterinary Zinc Bacitracin Market Price Analysis by Region (2021-2026)
- 5.6 Global Veterinary Zinc Bacitracin Production and Value, YOY Growth
- 5.6.1 North America Veterinary Zinc Bacitracin Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Veterinary Zinc Bacitracin Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Veterinary Zinc Bacitracin Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Veterinary Zinc Bacitracin Production Value Estimates and Forecasts (2021-2032)
6 Global Veterinary Zinc Bacitracin Consumption by Region
- 6.1 Global Veterinary Zinc Bacitracin Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Veterinary Zinc Bacitracin Consumption by Region (2021-2032)
- 6.2.1 Global Veterinary Zinc Bacitracin Consumption by Region: 2021-2026
- 6.2.2 Global Veterinary Zinc Bacitracin Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Veterinary Zinc Bacitracin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Veterinary Zinc Bacitracin Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Veterinary Zinc Bacitracin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Veterinary Zinc Bacitracin Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Veterinary Zinc Bacitracin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Veterinary Zinc Bacitracin Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Veterinary Zinc Bacitracin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Veterinary Zinc Bacitracin Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Veterinary Zinc Bacitracin Production by Type (2021-2032)
- 7.1.1 Global Veterinary Zinc Bacitracin Production by Type (2021-2032) & (MT)
- 7.1.2 Global Veterinary Zinc Bacitracin Production Market Share by Type (2021-2032)
- 7.2 Global Veterinary Zinc Bacitracin Production Value by Type (2021-2032)
- 7.2.1 Global Veterinary Zinc Bacitracin Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Veterinary Zinc Bacitracin Production Value Market Share by Type (2021-2032)
- 7.3 Global Veterinary Zinc Bacitracin Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Veterinary Zinc Bacitracin Production by Application (2021-2032)
- 8.1.1 Global Veterinary Zinc Bacitracin Production by Application (2021-2032) & (MT)
- 8.1.2 Global Veterinary Zinc Bacitracin Production Market Share by Application (2021-2032)
- 8.2 Global Veterinary Zinc Bacitracin Production Value by Application (2021-2032)
- 8.2.1 Global Veterinary Zinc Bacitracin Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Veterinary Zinc Bacitracin Production Value Market Share by Application (2021-2032)
- 8.3 Global Veterinary Zinc Bacitracin Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Veterinary Zinc Bacitracin Value Chain Analysis
- 9.1.1 Veterinary Zinc Bacitracin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Veterinary Zinc Bacitracin Production Mode & Process
- 9.2 Veterinary Zinc Bacitracin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Veterinary Zinc Bacitracin Distributors
- 9.2.3 Veterinary Zinc Bacitracin Customers
10 Global Veterinary Zinc Bacitracin Analyzing Market Dynamics
- 10.1 Veterinary Zinc Bacitracin Industry Trends
- 10.2 Veterinary Zinc Bacitracin Industry Drivers
- 10.3 Veterinary Zinc Bacitracin Industry Opportunities and Challenges
- 10.4 Veterinary Zinc Bacitracin Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst